Last reviewed · How we verify
ZSTK474
At a glance
| Generic name | ZSTK474 |
|---|---|
| Sponsor | Zenyaku Kogyo Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of ZSTK474 in Japanese Patients With Advanced Solid Malignancies (PHASE1)
- A Safety Study of Oral ZSTK474 in Patients With Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ZSTK474 CI brief — competitive landscape report
- ZSTK474 updates RSS · CI watch RSS
- Zenyaku Kogyo Co., Ltd. portfolio CI